Related Experiment Video

Updated: Aug 20, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Pathogenesis of prion diseases

Ursula Unterberger1, Till Voigtländer, Herbert Budka

  • 1Institute of Neurology, Medical University of Vienna, AKH, Austria.

Acta Neuropathologica
|January 13, 2005
PubMed

Insights

Prion diseases are fatal neurodegenerative disorders caused by misfolded prion proteins. Research is advancing understanding of prion spread and nerve cell damage, but therapies are still needed.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Prion diseases are rare, fatal neurological disorders.
  • They can be genetic, infectious, or sporadic.
  • Prions are abnormal, protease-resistant prion proteins (PrP(C)) that aggregate in the central nervous system (CNS).

Purpose of the Study:

  • To review the pathogenesis of prion diseases.
  • To discuss peripheral and central mechanisms of prion disease.
  • To highlight the need for therapeutic development.

Main Methods:

  • Literature review of prion disease pathogenesis.
  • Analysis of prion replication and spread.
  • Examination of mechanisms of neurodegeneration in prion diseases.

Main Results:

  • Prion diseases involve aggregates of misfolded prion proteins in the CNS.
  • Peripheral pathogenesis involves prion replication in lymphoid tissues before CNS spread.
  • Central pathogenesis includes prion spread within the CNS and mechanisms of nerve cell damage.

Conclusions:

  • Understanding prion disease pathogenesis requires studying both peripheral and central mechanisms.
  • Lymphoid tissues play a key role in peripheral prion replication.
  • While microglial neurotoxicity, oxidative stress, and complement activation are implicated, further research is needed to develop effective therapies for prion diseases.

More Related Videos

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster10:26

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster

Published on: March 12, 2018

Protein Misfolding Cyclic Amplification of Prions10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...